You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
格隆匯公告精選(港股)︱津上機牀中國(01651.HK)年度淨利潤增長63.0%至約7.82億元

【今日焦點】

津上機牀中國(01651.HK)年度淨利潤增長63.0%至約7.82億元

津上機牀中國(01651.HK)公佈,截至2025年3月31日止年度,集團在汽車零部件等主要下遊行業獲取的訂單穩步增加,銷售收入和淨利潤較上一財年分別同比增長36.6%及63.0%,至約人民幣42.62億元及人民幣7.82億元。得益於集團推行的各項降本增效工作,盈利水平明顯提升,毛利率較上一財年的28.7%增加約4.4個百分點,至33.1%。淨利潤率由上一財年的15.4%增加約3.0個百分點至18.4%。回顧年度內每股基本盈利約爲人民幣2.08元(上一財年:約人民幣1.26元)。董事會建議派發末期股息每股股份0.50港元。

【重大事項】

中國生態旅遊(01371.HK)中標廣東省電腦福利彩票銷售管理系統技術服務專案

東風集團股份(00489.HK)擬與日產成立合資公司 發力汽車出口業務

【財報業績】

醫渡科技(02158.HK)年度業績:大數據平臺和解決方案收入保持平穩增長,年度虧損同比大幅減虧38.9%

嘉利國際(01050.HK)年度權益持有人應佔溢利2.05億港元 同比增加21%

億都(國際控股)(00259.HK)年度綜合收入約10.39億港元 同比增加10.9%

民生國際(00938.HK)年度權益持有人應佔虧損擴大至約5.92億港元

元亨燃氣(00332.HK)預期2025財年淨虧損22億至26億元

中信資源(01205.HK)盈警:預期中期股東應佔綜合溢利同比減少約48%至66%

蒙古能源(00276.HK)年度擁有人應佔虧損13.77億港元

【運營數據】

滔搏(06110.HK):第一財季零售及批發業務總銷售額同比錄得中單位數下跌

【醫藥創新】

先瑞達醫療-B(06669.HK):外周高壓球囊擴張導管ARMONI-HP註冊申請獲國家藥監局批準

中國中藥(00570.HK):國家藥監局受理鬱樞達片的新藥註冊上市申請

【收購出售】

美麗田園醫療健康(02373.HK):CPE擬出售所持有的約5133萬股公司股份

【股權激勵】

嗶哩嗶哩-W(09626.HK)授出合共309萬份限制性股份單位

創勝集團-B(06628.HK)授出200萬份購股權

【增發供股】

首佳科技(00103.HK)按“20供3”基準發行供股股份

【增減持】

鉅子生物(02367.HK)獲控股股東Juzi Holding增持92.26萬股

【回購註銷】

騰訊控股(00700.HK)6月25日耗資5億港元回購97.9萬股

友邦保險(01299.HK)6月25日耗資1.77億港元回購250萬股

阿里巴巴-W(09988.HK)6月24日耗資999萬美元回購68.7萬股

首佳科技(00103.HK)擬回購不超1億港元公司股份

渣打集團(02888.HK)6月24日耗資912萬英鎊回購76.6萬股

美的集團(00300.HK)6月25日耗資4800萬元回購65.9萬股A股

保誠(02378.HK)6月24日耗資548.4萬英鎊回購60萬股

貝殼-W(02423.HK)6月24日耗資500萬美元回購81.7萬股

美的集團(00300.HK)註銷1109萬股回購股份

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account